Hepatitis C Treatment Options - Hepatitis C treatment difficult in older patients

Hepatitis C treatment difficult in older patients
Reuters UK - NEW YORK (Reuters Health) - Because of side effects, patients over the age of 60 with hepatitis C find it more difficult to stick with standard treatments than do their younger counterparts, according to a study in Japan. Impaired heart, lung and

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH
Medical News Today - Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm

First-Time Generic Approvals: Copegus, Tegretol, Roxicodone
Medscape News - Jan. 24, 2006 The US Food and Drug Administration (FDA) approved in December 2005 first-time generic 200-mg formulations of ribavirin and carbamazepine tablets, and 15- and 30-mg formulations of oxycodone HCl tablets. First-time doses (ie, no